RxDoctor Payments Data

Otis Wright, NP

Gerontology · Lancaster, CANPI 1104909688

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,673 and has fallen 93.1% since, to $116 in 2024. Among gerontology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,834in general payments, 2019–2025

Across 143 payments — averaging $26.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$427
  • Boehringer Ingelheim$379
  • Novo Nordisk$326
  • Regeneron Healthcare Solutions, Inc.$261
  • Teva Pharmaceuticals USA, Inc.$255
  • AstraZeneca$241
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$3,834100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,834 in reported general payments places this provider in the 90th percentile of 348 gerontology providers in California.

See all gerontology providers in California

Medicare billing

Part B allowed, 2024
$245,428
Medicare patients
286
Services billed
3,377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban25$14,651
Memantine Hcl19$1,719
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$999
Montelukast Sodium12$386
Atorvastatin Calcium28$378
Gabapentin15$246
Alendronate Sodium14$237
Donepezil Hcl18$203
Tramadol Hcl13$188
Lorazepam20$179
Trazodone Hcl14$131
Amlodipine Besylate12$106
Azithromycin13$106
Buspirone Hcl13$79
Metoprolol Tartrate12$50

Paid to pharmacies, not to this prescriber.

Other gerontology in Lancaster

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →